Protara Therapeutics, Inc. (TARA)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Jesse Shefferman
|
Co-founder, CEO, President & Director | 1.08M | -- | 1972 |
|
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.
|
Co-Founder, Chief R&D Officer | 789.45k | -- | 1981 |
|
Mr. Patrick Fabbio M.B.A.
|
Chief Financial Officer | 782.41k | -- | 1968 |
|
Ms. Hannah Fry
|
VP, Principal Accounting Officer & Controller | -- | -- | 1991 |
|
Ms. Justine O'Malley
|
Senior Vice President of Investor Relations & Corporate Affairs | -- | -- | -- |
|
Ms. Mary J. Grendell J.D.
|
General Counsel & Corporate Secretary | -- | -- | -- |
|
Dr. Shane Williams Ph.D.
|
Chief People Officer | -- | -- | -- |
|
Mr. William Conkling
|
Chief Commercial Officer | -- | -- | 1971 |
|
Carla Beckham M.D., Ph.D.
|
Lead Medical Director, Head of Clinical Development of TARA-002 in NMIBC & Board-Certified Urologist | -- | -- | -- |
|
Dr. Neal D. Shore F.A.C.S., M.D.
|
Medical Director of START Carolinas/ Carolina Urologic Research Center | -- | -- | -- |
Protara Therapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 46
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Corporate Governance
Upcoming Events
November 10, 2026 at 1:30 PM UTC
Protara Therapeutics, Inc. Earnings Date
Recent Events
May 20, 2026 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
